fda and tirzepatide approval for Zepbound (tirzepatide) injection, the first only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA ban on compounded tirzepatide:

Strength: 15MG

Drugmaker Novo Nordisk announces they are expanding access to its weight loss drug WeGovy with a new partnership with Weight Watchers.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have a welcome benefit in addition to weight loss and glycemic control, with new data pre...

Taking Ozempic (semaglutide) alongside prednisone requires careful medical oversight because corticosteroids can increase blood sugar while GLP-1 drugs lower it

Testosterone: The New Healthcare Wonder Solution In the realm of modern healthcare, testosterone replacement therapy (TRT) is fast becoming a game-changer

Understanding the Side Effects of GLP-1 Drugs